RenovoRx, Inc. (RNXT) has a market capitalization of $36.15M and trades at $1.03. The 52-week range is 0.701-1.45.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.2, Earnings Per Share (EPS) of $-0.32, annual revenue of $1.12M.
The stock has a beta of 1.22, operates in the Healthcare sector.
